相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases
Fereshte Abdolmaleki et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
The higher prevalence of multiple sclerosis among Iranian Georgians; new clues to the role of genetic factors
M. Etemadifar et al.
REVUE NEUROLOGIQUE (2020)
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction
Gijs Kooij et al.
HAEMATOLOGICA (2020)
α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients
Kjetil Bjornevik et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients
Kjetil Bjornevik et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis
Yan Zhang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology
Claudio Derada Troletti et al.
CELL DEATH & DISEASE (2019)
Multiple sclerosis risk factors contribute to onset heterogeneity
Farren B. S. Briggs et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress
Alessandro Leuti et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Lipoxin-Induced Phenotypic Changes in CD115+LY6Chi Monocytes TAM Precursors Inhibits Tumor Development
Natalia Mesquite de-Brito et al.
FRONTIERS IN ONCOLOGY (2019)
Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases
Pei Shang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions
Nan Chiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Resolution of inflammation during multiple sclerosis
F. Ruiz et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease
Paraskevi Krashia et al.
NATURE COMMUNICATIONS (2019)
Maresin 1 attenuates neuroinflammation in a mouse model of perioperative neurocognitive disorders
T. Yang et al.
BRITISH JOURNAL OF ANAESTHESIA (2019)
Resolution of inflammation in neuromyelitis optica spectrum disorders
Wang Xu et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis
Houda Abir Benabdoun et al.
ARTHRITIS RESEARCH & THERAPY (2019)
The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+T lymphocytes and B cells
Joana Machado-Santos et al.
BRAIN (2018)
ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages
Andres Laguna-Fernandez et al.
CIRCULATION (2018)
GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain
Sangsu Bang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Key roles for lipid mediators in the adaptive immune response
Parker F. Duffney et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clinical Course of Multiple Sclerosis
Sylvia Klineova et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions
Karim El Kholy et al.
FRONTIERS IN IMMUNOLOGY (2018)
Bioactive Lipids and Chronic Inflammation: Managing the Fire Within
Valerio Chiurchiu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Nutritional Intervention as an Essential Part of Multiple Sclerosis Treatment?
A. Penesova et al.
PHYSIOLOGICAL RESEARCH (2018)
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Tomas Olsson et al.
NATURE REVIEWS NEUROLOGY (2017)
Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling
Bochra Tourki et al.
FASEB JOURNAL (2017)
The specialized proresolving lipid mediator maresin 1 protects hepatocytes from lipotoxic and hypoxia-induced endoplasmic reticulum stress
Bibiana Rius et al.
FASEB JOURNAL (2017)
Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms
Charles N. Serhan
FASEB JOURNAL (2017)
Actions of SPM in regulating host responses in arthritis
Mauro Perretti et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology
Charles N. Serhan
MOLECULAR ASPECTS OF MEDICINE (2017)
Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors
Nan Chiang et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Polyunsaturated fatty acids and the risk of multiple sclerosis
Kjetil Bjornevik et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
New insights into the burden and costs of multiple sclerosis in Europe
Gisela Kobelt et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Polyunsaturated fatty acids and the risk of multiple sclerosis
Kjetil Bjornevik et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
New insights into the burden and costs of multiple sclerosis in Europe
Gisela Kobelt et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Peripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats
Beatrice Oehler et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Pro-Resolving Mediators in Regulating and Conferring Macrophage Function
Jesmond Dalli et al.
FRONTIERS IN IMMUNOLOGY (2017)
Protectin DX increases survival in a mouse model of sepsis by ameliorating inflammation and modulating macrophage phenotype
Haifa Xia et al.
SCIENTIFIC REPORTS (2017)
Disease-modifying treatments for multiple sclerosis - a review of approved medications
O. Torkildsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice
Joana R. Viola et al.
CIRCULATION RESEARCH (2016)
EPA- and DHA-derived resolvins' actions in inflammatory bowel disease
Raquel Cristina Schwanke et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
Melody G. Duvall et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study
Paolo Riccio et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue
Esther Titos et al.
JOURNAL OF IMMUNOLOGY (2016)
Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis
Bangwei Luo et al.
JOURNAL OF NEUROSCIENCE (2016)
Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses
Valerio Chiurchiu et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
Gabrielle Fredman et al.
NATURE COMMUNICATIONS (2016)
Resolvin D1 Reduces Emphysema and Chronic Inflammation
Hsi-Min Hsiao et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome
Charles N. Serhan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways
Jesmond Dalli et al.
FASEB JOURNAL (2015)
Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis
Laila M. Poisson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Progressive multiple sclerosis 1 Pathological mechanisms in progressive multiple sclerosis
Don H. Mahad et al.
LANCET NEUROLOGY (2015)
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
Marianna Cortese et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
Jesmond Dalli et al.
NATURE MEDICINE (2015)
Specialised lipid mediators and their targets
Daniel Crean et al.
SEMINARS IN IMMUNOLOGY (2015)
MARESIN 1 PREVENTS LIPOPOLYSACCHARIDE-INDUCED NEUTROPHIL SURVIVAL AND ACCELERATES RESOLUTION OF ACUTE LUNG INJURY
Jie Gong et al.
SHOCK (2015)
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
Marianna Cortese et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Lipid Mediators in the Resolution of Inflammation
Charles N. Serhan et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Neuroprotectin/protectin D1: endogenous biosynthesis and actions on diabetic macrophages in promoting wound healing and innervation impaired by diabetes
Song Hong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Novel Targets in Multiple Sclerosis: To Oxidative Stress and Beyond
Valerio Chiurchiu
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Resolvins RvD1 and 17(R)-RvD1 alleviate signs of inflammation in a rat model of endometriosis
Natalia Dmitrieva et al.
FERTILITY AND STERILITY (2014)
Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Christopher D. Buckley et al.
IMMUNITY (2014)
Functional Analysis via Standardized Whole-Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex Stimuli
Darragh Duffy et al.
IMMUNITY (2014)
The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review
Dimitrios Karussis
JOURNAL OF AUTOIMMUNITY (2014)
Resolvin D1 Stimulates Alveolar Fluid Clearance through Alveolar Epithelial Sodium Channel, Na,K-ATPase via ALX/cAMP/PI3K Pathway in Lipopolysaccharide-Induced Acute Lung Injury
Qian Wang et al.
JOURNAL OF IMMUNOLOGY (2014)
Resolvin D1 attenuates lipopolysaccharide induced acute lung injury through CXCL-12/CXCR4 pathway
Wang Yaxin et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Fatty fish intake is associated with decreased occurrence of multiple sclerosis
Maria Baarnhielm et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
ATLAS OF MULTIPLE SCLEROSIS 2013: A GROWING GLOBAL PROBLEM WITH WIDESPREAD INEQUITY
Paul Browne et al.
NEUROLOGY (2014)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Lipoxin A4 Prevents the Progression of De Novo and Established Endometriosis in a Mouse Model by Attenuating Prostaglandin E2 Production and Estrogen Signaling
Rajesh Kumar et al.
PLOS ONE (2014)
Plasticity of Leukocytic Exudates in Resolving Acute Inflammation Is Regulated by MicroRNA and Proresolving Mediators
Yongsheng Li et al.
IMMUNITY (2013)
Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis
George A. Jelinek et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2013)
Maresin 1, a Proresolving Lipid Mediator Derived from Omega-3 Polyunsaturated Fatty Acids, Exerts Protective Actions in Murine Models of Colitis
Rodrigo Marcon et al.
JOURNAL OF IMMUNOLOGY (2013)
Pathology and disease mechanisms in different stages of multiple sclerosis
Hans Lassmann
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury
O. Eickmeier et al.
MUCOSAL IMMUNOLOGY (2013)
Efficacy of Fish Oil on Serum of TNF alpha, IL-1 beta, and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1b
V. Ramirez-Ramirez et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Proresolution Lipid Mediators in Multiple Sclerosis - Differential, Disease Severity-Dependent Synthesis - A Clinical Pilot Trial
Harald Pruess et al.
PLOS ONE (2013)
Novel n-3 Immunoresolvents: Structures and Actions
Jesmond Dalli et al.
SCIENTIFIC REPORTS (2013)
Polyunsaturated fatty acids in multiple sclerosis therapy
S. Wergeland et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
Sriram Krishnamoorthy et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
New and emerging disease modifying therapies for multiple sclerosis
Shiv Saidha et al.
YEAR IN IMMUNOLOGY (2012)
ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study) A Randomized, Double-Blind, Placebo-Controlled Trial
Oivind Torkildsen et al.
ARCHIVES OF NEUROLOGY (2012)
Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
Charles N. Serhan et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
Charles N. Serhan et al.
FASEB JOURNAL (2012)
Multiple sclerosis
Alyssa Nylander et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat
Joan Claria et al.
JOURNAL OF IMMUNOLOGY (2012)
Resolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses
Alexandre P. Rogerio et al.
JOURNAL OF IMMUNOLOGY (2012)
Self-Limited versus Delayed Resolution of Acute Inflammation: Temporal Regulation of Pro-Resolving Mediators and MicroRNA
Gabrielle Fredman et al.
SCIENTIFIC REPORTS (2012)
Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution
Gabrielle Fredman et al.
BIOCHEMICAL JOURNAL (2011)
Metabolic Connections during Apoptotic Cell Engulfment
Claudia Z. Han et al.
CELL (2011)
Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice
Jason Hellmann et al.
FASEB JOURNAL (2011)
The resolution of inflammation: the devil in the flask and in the details
Charles N. Serhan
FASEB JOURNAL (2011)
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits
Antonio Recchiuti et al.
FASEB JOURNAL (2011)
Omega-3 Fatty Acid-Derived Mediators 17(R)-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice
Allisson Freire Bento et al.
JOURNAL OF IMMUNOLOGY (2011)
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Ranjan Dutta et al.
PROGRESS IN NEUROBIOLOGY (2011)
Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis
S. Nightingale et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
J. M. Fletcher et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Rare infections mimicking MS
Vesna V. Brinar et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Complementary and alternative medicine for the treatment of multiple sclerosis
Vijayshree Yadav et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis
Taisuke Ohira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Current Views on the Roles of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
Mohamed El-behi et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
The changing demographic pattern of multiple sclerosis epidemiology
Nils Koch-Henriksen et al.
LANCET NEUROLOGY (2010)
Multiple sclerosis genetics-is the glass half full, or half empty?
Jorge R. Oksenberg et al.
NATURE REVIEWS NEUROLOGY (2010)
A review of complementary and alternative medicine (CAM) by people with multiple sclerosis
Sherri A. Olsen
Occupational Therapy International (2009)
Adding fuel to fire: microRNAs as a new class of mediators of inflammation
F. J. Sheedy et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Clinically isolated syndrome: the rationale for early treatment
Giancarlo Comi
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Charles N. Serhan et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Omega-3 fatty acids and multiple sclerosis: relationship to depression
Robin L. Aupperle et al.
JOURNAL OF BEHAVIORAL MEDICINE (2008)
Chronological changes of CD4+ and CD8+ T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis
Yoshifumi Sonobe et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle
M. T. Kampman et al.
JOURNAL OF NEUROLOGY (2007)
Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways
Charles N. Serhan
ANNUAL REVIEW OF IMMUNOLOGY (2007)
The pathology of MS - New insights and potential clinical applications
Sean J. Pittock et al.
NEUROLOGIST (2007)
The differential diagnosis of multiple sclerosis
Loren A. Rolak et al.
NEUROLOGIST (2007)
Sex ratio of multiple sclerosis in Canada: a longitudinal study
Sarah-Michelle Orton et al.
LANCET NEUROLOGY (2006)
The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration
Stephen L. Hauser et al.
NEURON (2006)
Resolution of inflammation: The beginning programs the end
CN Serhan et al.
NATURE IMMUNOLOGY (2005)
Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients
B Weinstock-Guttman et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Symptomatic therapy and neurorehabilitation in multiple sclerosis
J Kesselring et al.
LANCET NEUROLOGY (2005)
Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entree for resoleomics
CN Serhan et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2004)
Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers
CN Serhan et al.
LIPIDS (2004)
A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution
CN Serhan
HISTOCHEMISTRY AND CELL BIOLOGY (2004)
Use of unconventional therapies by individuals with multiple sclerosis
S Nayak et al.
CLINICAL REHABILITATION (2003)
Lipid mediator class switching during acute inflammation: signals in resolution
BD Levy et al.
NATURE IMMUNOLOGY (2001)
Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
